• CD36-Mediated Lipid Signaling Drives Immune Escape in AML

  2026-07-28

  Guo et al. (2024) uncover a non-canonical lipid sensing pathway in AML cells, orchestrated by CD36, that suppresses T cell activity and confers resistance to hypomethylating agent therapy. These findings illuminate a critical metabolic mechanism of immune escape and suggest new directions for targeting metabolic vulnerabilities in leukemia.

• Meropenem: Advanced Strategies Against Gram-Negative Resista

  2026-07-28

  Explore the scientific underpinnings of Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, with a focus on its mechanism, resistance challenges, and innovative use in translational Gram-negative infection research.

• Applied Insights: Glycogen Colorimetric Assay Kit II in Meta

  2026-07-27

  The Glycogen Colorimetric Assay Kit II delivers high-throughput, interference-resistant glycogen quantification, empowering metabolic and circadian research with robust sensitivity. This article provides a workflow-driven guide, translating recent endurance training findings and real lab challenges into actionable protocols and troubleshooting strategies.

• LAG-3/TCR Proximity Modulates T Cell Suppression in Autoimmu

  2026-07-27

  Du et al. (2025) uncover that the spatial proximity between LAG-3 and the T cell receptor (TCR), rather than CD4, is essential for effective T cell suppression and autoimmunity control. Their mechanistic insights and bispecific antibody strategy open new avenues for targeted immune modulation in autoimmune diseases.

• Par6 Drives Processive Phosphorylation of Lgl via aPKC Inter

  2026-07-26

  This study reveals how Par6 facilitates efficient, processive phosphorylation of the Lgl protein by aPKC through a unique, dynamic interface, advancing our understanding of epithelial polarity mechanisms. The findings provide new structural and mechanistic insight into the regulation of protein phosphorylation signaling, with practical implications for phosphorylation state analysis in cell biology.

• Triptolide (PG490): Molecular Precision in Cancer and Inflam

  2026-07-25

  Explore the advanced mechanisms of Triptolide (PG490) in cancer research and immunology. Discover how this compound’s unique actions on transcriptional machinery and cell signaling unlock new strategies for targeting tumor growth and inflammatory disease.

• Digoxin in Translational Research: From Heart to Antiviral I

  2026-07-24

  This thought-leadership article examines Digoxin’s dual impact as a Na+/K+ ATPase pump inhibitor, bridging cardiac contractility research and experimental antiviral applications. We synthesize mechanistic insight, protocol guidance, and translational context to empower research teams navigating the evolving landscape of cardiovascular and infectious disease models.

• NSAID Cytotoxicity in Canine Osteosarcoma: Insights and Tool

  2026-07-24

  This study evaluated the cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cell lines, revealing that deracoxib is more potent than piroxicam but neither induces apoptosis at tested concentrations. The findings refine understanding of NSAID mechanisms in sarcoma models and underscore the need for integrin-targeted strategies in future cancer research.

• Defining Ca Channel Subtype Blockade: Insights from v-Agatox

  2026-07-23

  Sidach and Mintz's research refines the pharmacological differentiation of neuronal calcium channels by demonstrating that the spider toxin v-Agatoxin-IVA, while highly selective for P-type channels, also exhibits low-affinity blockade of N-type channels at higher concentrations. This nuanced understanding impacts experimental designs that rely on toxin-based channel classification and informs interpretation of neurophysiological data.

• Baicalin Methyl Ester: Reliable Solutions for Intestinal Bar

  2026-07-23

  This article delivers scenario-driven, evidence-based guidance for laboratory teams evaluating 'Baicalin methyl ester' (SKU N2884) in LPS-induced intestinal barrier damage assays. Integrating quantitative data and validated workflows, it demonstrates how APExBIO's compound ensures reproducibility and mechanistic clarity for advanced gut inflammation studies.

• Digoxin as a Precision Na+/K+ ATPase Pump Inhibitor in Trans

  2026-07-22

  Explore cutting-edge insights into Digoxin as a Na+/K+ ATPase pump inhibitor, focusing on translational assay design, cross-domain modeling, and its unique antiviral selectivity. This article delivers a deeper analytical perspective for researchers seeking robust cardiac and virology study solutions.

• Structural Flexibility of Cyclosporin Variants and Mitochond

  2026-07-22

  This study systematically compares cyclosporin variants B–E, revealing that only those with a flexible backbone, such as Cyclosporin A, effectively inhibit the mitochondrial permeability transition pore (MPTP). By integrating NMR spectroscopy and molecular dynamics with mitochondrial assays, the research provides a mechanistic basis for selecting cyclosporin congeners in immunosuppression and mitochondrial studies.

• Tubastatin A: Redefining HDAC6 Inhibition in Myocardial Prot

  2026-07-21

  Explore how Tubastatin A, a highly selective HDAC6 inhibitor, advances myocardial protection by targeting pyroptosis and necroptosis. This article offers a unique translational perspective linking epigenetic modulation to cardiac injury models.

• Merbromin (BA1653): Mechanism, Evidence, and Research Protoc

  2026-07-21

  Merbromin (Mercury dibromofluorescein disodium salt) is a validated fluorescent probe and mixed-type enzyme inhibitor, widely used for protein–ligand binding and antiviral screening. This article reviews mechanistic insights, quantitative benchmarks, and protocol parameters relevant to biochemical research, citing APExBIO’s research-grade Merbromin product.

• APOL1 Evolution, APOL3 Interaction, and Splice Isoforms in C

  2026-07-20

  This study provides a comprehensive analysis of the molecular evolution of APOL1 variants, their splice isoforms, and the interaction with APOL3, illuminating mechanisms underlying both trypanosome resistance and kidney injury. The findings advance understanding of how genetic and molecular diversity in APOL1 modulates cellular susceptibility to injury, with important implications for disease modeling and translational nephrology.

8288 records 4/553 page Previous Next 12345 下5页 Last page